Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.97
0.00 (0.00%)
Market open: Aug 12, 2026, 2:21 PM EDT
1.98
+0.01 (0.51%)
Previous after-hours: Aug 11, 2026, 4:10 PM EDT
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
| Name | Position |
|---|---|
| Mr. Ferdinand Groenewald | Vice President of Finance & Corporate Secretary |
| Mr. Holger Weis CPA | Chairman of the Board & CEO |
| Date | Type | Document |
|---|---|---|
| 2026-07-06 | S-8 | tcrt-20260703.htm |
| 2026-06-29 | 8-K | tcrt-20260629.htm |
| 2026-05-26 | 8-K | tcrt-20260526.htm |
| 2026-05-18 | 8-K | tcrt-20260302.htm |
| 2026-05-15 | 10-Q | tcrt-20260331.htm |
| 2026-04-30 | 10-K/A | tcrt-20251231.htm |
| 2026-04-15 | 8-K | tcrt-20260409.htm |
| 2026-03-31 | 10-K | tcrt-20251231.htm |
| 2026-03-02 | 8-K | tcrt-20260302.htm |
| 2026-01-08 | 8-K | tcrt-20260108.htm |